Cargando…

Biological insights into the role of TET2 in T cell lymphomas

Peripheral T cell lymphomas (PTCL) are a heterogenous group of mature T cell lymphomas with an overall poor prognosis. Understanding the molecular heterogeneity in PTCL subtypes may lead to improved understanding of the underlying biological mechanisms driving these diseases. Mutations in the epigen...

Descripción completa

Detalles Bibliográficos
Autor principal:	Carty, Shannon A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570544/ https://www.ncbi.nlm.nih.gov/pubmed/37841428 http://dx.doi.org/10.3389/fonc.2023.1199108

Ejemplares similares

Cigarette smoke stimulates clonal expansion of Jak2(V617F) and Tet2(-/-) cells
por: Ramanathan, Gajalakshmi, et al.
Publicado: (2023)

TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
por: Feng, Yimei, et al.
Publicado: (2019)

Update on Biology of Cutaneous T-Cell Lymphoma
por: Phyo, Zaw H., et al.
Publicado: (2020)

DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
por: Sato, Hanae, et al.
Publicado: (2016)

The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
por: Brągiel-Pieczonka, Aneta, et al.
Publicado: (2022)

An Update on Molecular Biology of Cutaneous T Cell Lymphoma
por: Walia, Ritika, et al.
Publicado: (2020)

Biological Approaches to Aggressive Cutaneous B-Cell Lymphomas
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
por: Li, Hua, et al.
Publicado: (2013)

Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism
por: Zhang, Jingbo, et al.
Publicado: (2022)

Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
por: Marques-Piubelli, Mario L., et al.
Publicado: (2023)

Editorial: NK/T-Cell Lymphoma: Biology, Prognostics, Prediction, and Treatment
por: El Cheikh, Jean, et al.
Publicado: (2022)

Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma
por: Hu, Lina, et al.
Publicado: (2022)

TET1 Isoforms Have Distinct Expression Pattern, Localization and Regulation in Breast Cancer
por: Alzahayqa, Mahmoud, et al.
Publicado: (2022)

Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1
por: Yan, Yi-lin, et al.
Publicado: (2020)

The Role of Noncoding RNAs in B-Cell Lymphoma
por: Li, Jingwen, et al.
Publicado: (2020)

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability
por: Zain, Jasmine, et al.
Publicado: (2023)

Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights
por: Chemi, Francesca, et al.
Publicado: (2021)

New Insights into TETs in Psychiatric Disorders
por: Zhan, Wenxia, et al.
Publicado: (2022)

P1271: ELUCIDATING TUMOR SUPPRESSOR FUNCTIONS OF TET2 IN B CELL LYMPHOMAS
por: Kinz, N., et al.
Publicado: (2022)

Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers
por: Xie, Shangdan, et al.
Publicado: (2021)

The role of transplantation in Hodgkin lymphoma
por: Maranzano, Michael, et al.
Publicado: (2023)

Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019)

The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas
por: Pham, Lan V., et al.
Publicado: (2018)

In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1
por: Luo, Yixin, et al.
Publicado: (2022)

BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role
por: Pileri, Alessandro, et al.
Publicado: (2020)

Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
por: Shenoy, N, et al.
Publicado: (2017)

Loss of TET2 and TET3 in regulatory T cells unleashes effector function
por: Yue, Xiaojing, et al.
Publicado: (2019)

TET2 Clonal Hematopoiesis Is Associated With Anthracycline-Induced Cardiotoxicity in Patients With Lymphoma
por: Hatakeyama, Kiwamu, et al.
Publicado: (2022)

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
por: Roccuzzo, Gabriele, et al.
Publicado: (2021)

Do circulating tumor cells play a role in coagulation and thrombosis?
por: Tormoen, Garth W., et al.
Publicado: (2012)

Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice
por: Muto, H, et al.
Publicado: (2014)

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia
por: Nabil, Reem, et al.
Publicado: (2022)

Targeting the Bcl-2 Family in B Cell Lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Newly Identified Roles of PML in Stem Cell Biology
por: Ito, Kyoko, et al.
Publicado: (2013)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling
por: Paggetti, Jérôme, et al.
Publicado: (2021)

Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination
por: Cakouros, Dimitrios, et al.
Publicado: (2019)

Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency
por: Costa, Yael, et al.
Publicado: (2013)

The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development
por: Lian, Hao, et al.
Publicado: (2016)

The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma
por: Tyler, Kelly H., et al.
Publicado: (2015)

TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology
por: Tsagaratou, Ageliki
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8cpk3a3mfljd4q305e3sc7csr3